Express Scripts moving to performance-based contracts with drug industry, out of carve-outs, exec says.
Executive Summary
EXPRESS SCRIPTS SEES MOVE AWAY FROM "ERA OF DISCOUNTING," anticipating more performance-based contracts with the pharmaceutical sector over the next three years, CEO Barrett Toan told analysts at the Alex. Brown health care seminar. The independent PBM covering approximately 9 mil. lives "will be increasingly involved in strategic relationships with the pharmaceutical manufacturing sector" in terms of pharmacy services, Toan said.